Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2020; 45(4): 758-761


Seroprevalence of Human Immunodeficiency Virus among Injecting Drug Users in District Sanghar, Sindh, Pakistan

Abdul Nabi Jatt, Abdul Sami Dahri, Shaista Bano, Sarfraz Ali Tunio, Babar Aijaz Memon, Asim Patrick.




Abstract

Objective: To investigate seroprevalence of Human Immunodeficiency Virus (HIV) among injection drug users (IDUs) at District Sanghar, Pakistan.
Methodology: A total of 119 blood samples were collected from IDUs shooting drugs at different sites across District Sanghar. Demographic data regarding age, gender, marital status, education, and occupation were collected. Presence of HIV was detected using 4th Generation immunochromatographic Alere Combo kits Ag/Ab HIV-1/2 as per manufacturerÂ’s instructions.
Results: We found that 24(20.17%) samples were positive for HIV infection. Among them, male IDUs were 22(18.49%), while 2(1.68%) were female IDUs. Taluka-wise frequency of HIV among IDUs revealed that highest cases 10.08% (n=12) in taluka Tando Adam, followed by taluka Shahdadpur having 5.88% (n=07) cases. Taluka Sanghar had 3.36% (n=04) cases while least number of positive cases was found in taluka Sinjhoro 0.8% (n=01).
Conclusion: HIV was more prevalent in male IDUs as compared to female. High prevalence of HIV among IDUs in district Sanghar is alarming and warrants urgent attention of health professionals for strict measures to control the transmission of HIV in IDUs and general population.

Key words: Seroprevalence, injecting drug users, HIV, AIDS.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.